CRL

Charles River Laboratories International Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth↓ 1/10
  • Value↓ 2/10
Charles River Laboratories International sales and earnings growth
CRL Growth
Low
  • Revenue Y/Y↓ -0.85%
  • EPS Y/Y↓ -1555.00%
  • FCF Y/Y↓ 3.37%
Charles River Laboratories International gross and profit margin trends
CRL Profitability
Neutral
  • Gross margin ↑ 33.00%
  • EPS margin↓ -3.60%
  • ROIC 5Y↓ 7.91%
Charles River Laboratories International net debt vs free cash flow
CRL Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 4.5
  • Interest coverage↓ 0.1

Charles River Laboratories International stock volatility is higher than the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗